Eton Pharmaceuticals/$ETON
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Eton Pharmaceuticals
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Ticker
$ETON
Sector
Primary listing
Employees
44
Headquarters
Website
ETON Metrics
BasicAdvanced
$616M
-
-$0.17
1.24
-
Price and volume
Market cap
$616M
Beta
1.24
52-week high
$24.46
52-week low
$11.09
Average daily volume
392K
Financial strength
Current ratio
1.574
Quick ratio
0.979
Long term debt to equity
84.993
Total debt to equity
118.846
Interest coverage (TTM)
1.01%
Profitability
EBITDA (TTM)
8.875
Gross margin (TTM)
59.83%
Net profit margin (TTM)
-5.75%
Operating margin (TTM)
6.04%
Effective tax rate (TTM)
-0.94%
Revenue per employee (TTM)
$1,820,000
Management effectiveness
Return on assets (TTM)
3.59%
Return on equity (TTM)
-18.19%
Valuation
Price to revenue (TTM)
7.6
Price to book
23.35
Price to tangible book (TTM)
-129.28
Price to free cash flow (TTM)
59.62
Free cash flow yield (TTM)
1.68%
Free cash flow per share (TTM)
0.379
Growth
Revenue change (TTM)
104.94%
Earnings per share change (TTM)
15.82%
3-year revenue growth (CAGR)
55.53%
3-year earnings per share growth (CAGR)
-21.89%
What the Analysts think about ETON
Analyst ratings (Buy, Hold, Sell) for Eton Pharmaceuticals stock.
ETON Financial Performance
Revenues and expenses
ETON Earnings Performance
Company profitability
ETON News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Eton Pharmaceuticals stock?
Eton Pharmaceuticals (ETON) has a market cap of $616M as of April 01, 2026.
What is the P/E ratio for Eton Pharmaceuticals stock?
The price to earnings (P/E) ratio for Eton Pharmaceuticals (ETON) stock is 0 as of April 01, 2026.
Does Eton Pharmaceuticals stock pay dividends?
No, Eton Pharmaceuticals (ETON) stock does not pay dividends to its shareholders as of April 01, 2026.
When is the next Eton Pharmaceuticals dividend payment date?
Eton Pharmaceuticals (ETON) stock does not pay dividends to its shareholders.
What is the beta indicator for Eton Pharmaceuticals?
Eton Pharmaceuticals (ETON) has a beta rating of 1.24. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.